TRIB — Trinity Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapValue Trap

Annual balance sheet for Trinity Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	20-F	20-F	6-K
Standards:	IFRS	IFRS	IFRS	—	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	16.4	27.3	25.9	6.58	3.69
Net Total Accounts Receivable
Net Total Receivables	22.4	24.6	15.7	15.7	15.4
Total Inventory
Prepaid Expenses
Total Current Assets	71.4	83.3	72.7	46.7	39
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.29	8.55	5.92	5.68	1.89
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	131	130	119	92.1	59.4
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	19.4	27.1	100	17.3	15
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	126	133	119	94.3	83.4
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	4.71	-2.22	-0.319	-2.18	-23.9
Total Liabilities & Shareholders' Equity	131	130	119	92.1	59.4
Total Common Shares Outstanding